002728 特一药业
交易中 07-03 09:30:45
资讯
新帖
简况
7月1日特一药业涨5.03%,兴全中证800六个月持有指数A基金重仓该股
证券之星 · 07-01 16:48
7月1日特一药业涨5.03%,兴全中证800六个月持有指数A基金重仓该股
股市必读:特一药业(002728)6月30日董秘有最新回复
证券之星 · 07-01 01:28
股市必读:特一药业(002728)6月30日董秘有最新回复
特一药业:公司以中成药为主提供利润
证券之星 · 06-30 15:54
特一药业:公司以中成药为主提供利润
6月29日特一药业涨10.00%,兴全中证800六个月持有指数A基金重仓该股
证券之星 · 06-29
6月29日特一药业涨10.00%,兴全中证800六个月持有指数A基金重仓该股
异动快报:特一药业(002728)6月29日9点59分触及涨停板
证券之星 · 06-29
异动快报:特一药业(002728)6月29日9点59分触及涨停板
6月26日特一药业跌6.54%,兴全中证800六个月持有指数A基金重仓该股
证券之星 · 06-26
6月26日特一药业跌6.54%,兴全中证800六个月持有指数A基金重仓该股
股市必读:特一药业6月23日涨停收盘,收盘价8.82元
证券之星 · 06-24
股市必读:特一药业6月23日涨停收盘,收盘价8.82元
6月23日特一药业涨9.98%,兴全中证800六个月持有指数A基金重仓该股
证券之星 · 06-23
6月23日特一药业涨9.98%,兴全中证800六个月持有指数A基金重仓该股
异动快报:特一药业(002728)6月23日9点39分触及涨停板
证券之星 · 06-23
异动快报:特一药业(002728)6月23日9点39分触及涨停板
特一药业(002728)披露部分募投项目延期公告,6月17日股价下跌1.58%
证券之星 · 06-17
特一药业(002728)披露部分募投项目延期公告,6月17日股价下跌1.58%
特一药业(002728)披露2026年限制性股票激励计划首次授予公告,5月25日股价下跌1.22%
证券之星 · 05-25
特一药业(002728)披露2026年限制性股票激励计划首次授予公告,5月25日股价下跌1.22%
特一药业(002728.SZ)发布一季度业绩,归母净利润2576.32万元,同比下降18.39%
智通财经 · 04-27
特一药业(002728.SZ)发布一季度业绩,归母净利润2576.32万元,同比下降18.39%
特一药业(002728)披露2026年一季度报告,4月27日股价上涨1.17%
证券之星 · 04-27
特一药业(002728)披露2026年一季度报告,4月27日股价上涨1.17%
特一药业(002728)披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明,4月17日股价下跌2.37%
证券之星 · 04-17
特一药业(002728)披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明,4月17日股价下跌2.37%
股市必读:特一药业(002728)4月3日董秘有最新回复
证券之星 · 04-07
股市必读:特一药业(002728)4月3日董秘有最新回复
特一药业(002728.SZ):硫酸氨基葡萄糖胶囊取得药品注册证书
智通财经 · 04-03
特一药业(002728.SZ):硫酸氨基葡萄糖胶囊取得药品注册证书
特一药业:销售费用同比增长98.01%
证券之星 · 04-03
特一药业:销售费用同比增长98.01%
特一药业(002728)披露2026年限制性股票激励计划(草案),4月2日股价上涨1.33%
证券之星 · 04-02
特一药业(002728)披露2026年限制性股票激励计划(草案),4月2日股价上涨1.33%
特一药业(002728.SZ)拟授出1372.96万股限制性股票
智通财经 · 04-01
特一药业(002728.SZ)拟授出1372.96万股限制性股票
股市必读:特一药业(002728)3月23日收盘跌5.03%,主力净流出253.02万元
证券之星 · 03-24
股市必读:特一药业(002728)3月23日收盘跌5.03%,主力净流出253.02万元
加载更多
公司概况
公司名称:
特一药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2014-07-31
主营业务:
特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品是止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒、脑乐静胶囊。公司及其全资子公司海力制药、新宁制药均为高新技术企业,同时公司被认定为省级企业技术中心。
发行价格:
14.00
{"stockData":{"symbol":"002728","market":"SZ","secType":"STK","nameCN":"特一药业","latestPrice":9.46,"timestamp":1783042245000,"preClose":9.39,"halted":0,"volume":719300,"delay":0,"changeRate":0.0075,"floatShares":501000000,"shares":513000000,"eps":0.1479,"marketStatus":"交易中","change":0.07,"latestTime":"07-03 09:30:45","open":9.39,"high":9.53,"low":9.38,"amount":6788500,"amplitude":0.016,"askPrice":9.46,"askSize":13,"bidPrice":9.45,"bidSize":155,"shortable":0,"etf":0,"ttmEps":0.1479,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1783049400000},"marketStatusCode":2,"adr":0,"adjPreClose":9.39,"symbolType":"stock","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":10.33,"lowLimit":8.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":513309812,"isCdr":false,"pbRate":2.61,"roa":"--","peRate":63.962137,"roe":"1.4%","epsLYR":0.16,"committee":0.358268,"marketValue":4856000000,"turnoverRate":0.0014,"status":0,"floatMarketCap":4742000000},"requestUrl":"/m/hq/s/002728","defaultTab":"news","newsList":[{"id":"2648516681","title":"7月1日特一药业涨5.03%,兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648516681?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:48","pubTimestamp":1782895708,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日特一药业涨5.03%,收盘报9.61元,换手率11.08%,成交量55.56万手,成交额5.19亿元。重仓特一药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","159800","000906.SH","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648565644","title":"股市必读:特一药业(002728)6月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648565644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648565644?lang=zh_cn&edition=full","pubTime":"2026-07-01 01:28","pubTimestamp":1782840492,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,特一药业报收于9.15元,上涨3.98%,换手率10.43%,成交量52.29万手,成交额4.74亿元。公司以中成药为主提供利润,化学制剂药及原料药提供稳定现金流。在渠道布局上,均依托止咳宝片的营销渠道,其中:皮肤病血毒丸、降糖舒丸主打第三终端市场;脑乐静胶囊、独活寄生颗粒主打线上销售。各细分市场拓展均取得较好成效。公司暂无开展玛硒洛沙韦相关研发。当日关注点交易信息汇总:6月30日主力资金净流入3155.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100000801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647533220","title":"特一药业:公司以中成药为主提供利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2647533220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647533220?lang=zh_cn&edition=full","pubTime":"2026-06-30 15:54","pubTimestamp":1782806051,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业06月30日在投资者关系平台上答复投资者关心的问题。公司后续创新研发侧重自研还是外部合作引进创新药业绩形成增量特一药业回复:您好,感谢您对公司的关注。公司以中成药为主提供利润,化学制剂药及原料药提供稳定现金流。公司坚持“1+N”产品策略,以止咳宝片为核心,重点培育皮肤病血毒丸、降糖舒丸、独活寄生颗粒、脑乐静胶囊四个梯队产品。公司暂无开展玛硒洛沙韦相关研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000025943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322824","title":"6月29日特一药业涨10.00%,兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322824?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:43","pubTimestamp":1782722601,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日特一药业涨10.00%,收盘报8.8元,换手率3.78%,成交量18.93万手,成交额1.61亿元。重仓特一药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159800","BK0201","000906.SH","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647426953","title":"异动快报:特一药业(002728)6月29日9点59分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647426953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647426953?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:01","pubTimestamp":1782698472,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息,9点59分特一药业(002728)触及涨停板。其所属行业中药目前下跌。领涨股为太龙药业。该股为长寿药NMN,流感,医美概念热股,当日长寿药NMN概念上涨0.75%。6月26日的资金流向数据方面,主力资金净流出1324.84万元,占总成交额8.18%,游资资金净流出1037.45万元,占总成交额6.41%,散户资金净流入2362.28万元,占总成交额14.59%。近5日资金流向一览见下表:特一药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900007138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646635887","title":"6月26日特一药业跌6.54%,兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646635887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646635887?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:52","pubTimestamp":1782463972,"startTime":"0","endTime":"0","summary":"证券之星消息,6月26日特一药业跌6.54%,收盘报8.0元,换手率3.93%,成交量19.68万手,成交额1.62亿元。重仓特一药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000906.SH","BK0239","BK0201","002728","159800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645538878","title":"股市必读:特一药业6月23日涨停收盘,收盘价8.82元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645538878","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645538878?lang=zh_cn&edition=full","pubTime":"2026-06-24 01:00","pubTimestamp":1782234043,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,特一药业报收于8.82元,上涨9.98%,涨停,换手率3.0%,成交量15.02万手,成交额1.29亿元。交易信息汇总股价提醒特一药业6月23日涨停收盘,收盘价8.82元;9点39分涨停后未打开,截至收盘封单资金为5799.85万元,占其流通市值1.31%。资金流向6月23日主力资金净流入6217.73万元,占总成交额0.0%;游资资金净流出2774.23万元,占总成交额0.0%;散户资金净流出3443.51万元,占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400000895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645881675","title":"6月23日特一药业涨9.98%,兴全中证800六个月持有指数A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645881675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645881675?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:34","pubTimestamp":1782203697,"startTime":"0","endTime":"0","summary":"证券之星消息,6月23日特一药业涨9.98%,收盘报8.82元,换手率3.0%,成交量15.02万手,成交额1.29亿元。重仓特一药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为兴证全球基金的兴全中证800六个月持有指数A。兴全中证800六个月持有指数A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300027867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000906.SH","BK0201","159800","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645001638","title":"异动快报:特一药业(002728)6月23日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2645001638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645001638?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:46","pubTimestamp":1782179178,"startTime":"0","endTime":"0","summary":"证券之星6月23日盘中消息,9点39分特一药业(002728)触及涨停板。其所属行业中药目前上涨。领涨股为粤万年青。该股为化学原料药,医药,中药概念热股,当日化学原料药概念上涨3.09%,医药概念上涨2.96%,中药概念上涨2.93%。6月22日的资金流向数据方面,主力资金净流入149.31万元,占总成交额1.72%,游资资金净流出135.99万元,占总成交额1.56%,散户资金净流出13.32万元,占总成交额0.15%。近5日资金流向一览见下表:特一药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300009860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644747416","title":"特一药业(002728)披露部分募投项目延期公告,6月17日股价下跌1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644747416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644747416?lang=zh_cn&edition=full","pubTime":"2026-06-17 23:18","pubTimestamp":1781709497,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,特一药业报收于8.12元,较前一交易日下跌1.58%,最新总市值为41.68亿元。近日,特一药业集团股份有限公司披露《关于部分募投项目延期的公告》。公告显示,公司于2026年6月17日召开第六届董事会第十次会议,审议通过《关于部分募投项目延期的议案》,决定将“特一药业集团股份有限公司职工宿舍建设项目”达到预定可使用状态日期由2026年6月30日调整为2026年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638556850","title":"特一药业(002728)披露2026年限制性股票激励计划首次授予公告,5月25日股价下跌1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638556850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638556850?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:40","pubTimestamp":1779720026,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘,特一药业报收于8.91元,较前一交易日下跌1.22%,最新总市值为45.74亿元。近日,特一药业集团股份有限公司发布《关于向公司2026年限制性股票激励计划激励对象首次授予限制性股票的公告》。公告显示,公司于2026年5月25日召开第六届董事会第九次会议,确定2026年限制性股票激励计划首次授予日为2026年5月25日,向174名激励对象首次授予1,116.30万股限制性股票,授予价格为7.37元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002728","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630394047","title":"特一药业(002728.SZ)发布一季度业绩,归母净利润2576.32万元,同比下降18.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630394047","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630394047?lang=zh_cn&edition=full","pubTime":"2026-04-27 21:09","pubTimestamp":1777295340,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)发布2026年第一季度报告,第一季度,公司实现营业收入2.1亿元,同比下降28.89%。归属于上市公司股东的净利润2576.32万元,同比下降18.39%。归属于上市公司股东的扣除非经常性损益的净利润2486.46万元,同比下降21.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630360031","title":"特一药业(002728)披露2026年一季度报告,4月27日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360031","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630360031?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:46","pubTimestamp":1777286778,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,特一药业报收于10.35元,较前一交易日上涨1.17%,最新总市值为53.13亿元。该股当日开盘10.26元,最高10.35元,最低10.03元,成交额达1.27亿元,换手率为3.75%。近日,特一药业披露《2026年第一季度报告》。报告显示,公司2026年第一季度营业收入为209,871,725.36元,同比下降28.89%;归属于上市公司股东的净利润为25,763,241.72元,同比下降18.39%;经营活动产生的现金流量净额为11,675,178.57元,同比下降86.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628078812","title":"特一药业(002728)披露2026年限制性股票激励计划首次授予激励对象名单核查意见及公示情况说明,4月17日股价下跌2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628078812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628078812?lang=zh_cn&edition=full","pubTime":"2026-04-17 22:14","pubTimestamp":1776435257,"startTime":"0","endTime":"0","summary":"近日,特一药业集团股份有限公司披露《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的核查意见及公示情况说明》。公告显示,公司于2026年3月31日召开第六届董事会第七次会议,审议通过《2026年限制性股票激励计划(草案)》及其摘要。公司于2026年4月2日至4月12日在公司网站公示了首次授予激励对象的姓名及职务,公示期间未收到异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700045735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625260331","title":"股市必读:特一药业(002728)4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625260331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625260331?lang=zh_cn&edition=full","pubTime":"2026-04-07 01:24","pubTimestamp":1775496251,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,特一药业报收于11.0元,下跌3.59%,换手率7.87%,成交量26.12万手,成交额2.91亿元。来自公司公告汇总:特一药业全资子公司获硫酸氨基葡萄糖胶囊《药品注册证书》,该产品按(甲类)非处方药管理。公司公告汇总关于举行2025年度网上业绩说明会的公告特一药业集团股份有限公司将于2026年4月13日15:00-17:00在全景网举办2025年度网上业绩说明会,投资者可通过全景网“投资者关系互动平台”参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656070","title":"特一药业(002728.SZ):硫酸氨基葡萄糖胶囊取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656070","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624656070?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:25","pubTimestamp":1775208356,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)公告,公司全资子公司海南海力制药有限公司(简称“海力制药”)于近日收到国家药品监督管理局核准签发的硫酸氨基葡萄糖胶囊的《药品注册证书》。硫酸氨基葡萄糖胶囊适用于原发性及继发性骨关节炎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特一药业(002728.SZ):硫酸氨基葡萄糖胶囊取得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002728","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655262","title":"特一药业:销售费用同比增长98.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655262","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655262?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:30","pubTimestamp":1775205033,"startTime":"0","endTime":"0","summary":"证券之星消息,特一药业04月03日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,2025年公司净利润大增298%,但销售费用激增98%远超营收增速,请问营销投入具体去向及可持续性?公司2025年销售费用同比增长98.01%,主要因加大数字化营销、市场推广等投入,后续将强化精细化运营,兼顾品牌建设与经营业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300032037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507153","title":"特一药业(002728)披露2026年限制性股票激励计划(草案),4月2日股价上涨1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624507153?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:25","pubTimestamp":1775139957,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,特一药业报收于11.41元,较前一交易日上涨1.33%,最新总市值为58.57亿元。该股当日开盘11.26元,最高11.67元,最低11.18元,成交额达4.64亿元,换手率为12.28%。近日,特一药业集团股份有限公司披露《2026年限制性股票激励计划(草案)》。公告显示,本计划拟授予限制性股票总计1,372.9618万股,占公司股本总额的2.67%,其中首次授予1,143.80万股,预留229.1618万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624359576","title":"特一药业(002728.SZ)拟授出1372.96万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2624359576","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624359576?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:37","pubTimestamp":1775032678,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特一药业(002728.SZ)披露2026年限制性股票激励计划(草案),激励计划拟向激励对象(首次拟授予的总人数为197人)授予限制性股票总计1372.9618万股(其中首次授予权益1143.80万股),授予价格(含预留)为7.37元/股。本激励计划的有效期为自首次授予限制性股票登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销完毕之日止,最长不超过48个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0201","002728"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084813","title":"股市必读:特一药业(002728)3月23日收盘跌5.03%,主力净流出253.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084813","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621084813?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:09","pubTimestamp":1774296549,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,特一药业报收于10.19元,下跌5.03%,换手率4.7%,成交量17.72万手,成交额1.83亿元。当日关注点来自交易信息汇总:特一药业股价连续3日下跌,3月23日收跌5.03%,主力资金当日净流出253.02万元。股本股东变化因股权激励对象行权,公司股份自2025年6月1日至2025年12月31日增加744,378股,总股本由512,565,434股增至513,309,812股,注册资本相应由512,565,434元变更为513,309,812元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002728","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783042248835,"stockEarnings":[{"period":"1week","weight":0.097},{"period":"1month","weight":0.092},{"period":"3month","weight":-0.1304},{"period":"6month","weight":-0.1184},{"period":"1year","weight":0.1274},{"period":"ytd","weight":-0.1184}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0113},{"period":"3month","weight":0.0384},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"特一药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"74487人(较上一季度减少8.62%)","perCapita":"6730股","listingDate":"2014-07-31","address":"广东省江门市台山市台城长兴路9、11号","registeredCapital":"51330万元","survey":" 特一药业集团股份有限公司的主营业务是中成药品、化学制剂药品、化学原料药的研发、生产和销售。公司的主要产品是止咳宝片、感冒灵颗粒、血塞通分散片、银杏叶分散片、益心舒颗粒、铝碳酸镁咀嚼片、枫蓼肠胃康片、奥美拉唑肠溶胶囊、皮肤病血毒丸、小儿咳喘灵颗粒、金匮肾气片、降糖舒丸、独活寄生颗粒、脑乐静胶囊。公司及其全资子公司海力制药、新宁制药均为高新技术企业,同时公司被认定为省级企业技术中心。","listedPrice":14},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特一药业,002728,特一药业股票,特一药业股票老虎,特一药业股票老虎国际,特一药业行情,特一药业股票行情,特一药业股价,特一药业股市,特一药业股票价格,特一药业股票交易,特一药业股票购买,特一药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特一药业(002728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特一药业(002728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}